WeVote
Log In

Bill

Bill

HB 293

Continuous Glucose Monitors

2026 Regular Session Introduced by Gallop Franklin

Florida legislation addressing continuous glucose monitor access or coverage requirements for diabetes patients, currently in committee review.

Died in Health Care Facilities & Systems Subcommittee
#socialwelfare
0
WeVote Research Nonpartisan
Bill Summary · HB 293

Legislative bill overview

HB 293 appears to address continuous glucose monitor (CGM) access or coverage in Florida, though the specific provisions are not detailed in the filing information provided. The bill has been referred to relevant health care committees for review and is currently in early legislative stages following its initial filing.

Why is this important

CGMs are critical medical devices for diabetes management that provide real-time blood sugar readings, improving health outcomes and reducing complications. Legislation in this area typically affects insurance coverage, patient access, and healthcare costs for the approximately 2.8 million Floridians with diabetes.

Potential points of contention

  • Insurance coverage mandates — Requiring insurers to cover CGMs increases premiums and administrative costs, while opponents argue access should be prioritized over cost concerns
  • Device selection and prescribing authority — Questions about whether physicians or insurers determine which CGM brands are covered, and whether patients can switch devices based on preference
  • Medicaid and uninsured populations — Disputes over whether the state should expand CGM coverage to Medicaid recipients and how to serve uninsured diabetics

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.